2024-11-19 01:23:17
Harbour BioMed Announces Two China NMPA Clearances for Clinical Trials for Phase I & Combination Therapy of Next Generation Anti-CTLA-4 Antibody for Treatment of Solid Tumors
Health/ 2023-07-22
Harbour BioMed Announces Two China NMPA ...

CAMBRIDGE,Mass. andROTTERDAM,Netherlands andSUZHOU,China,Sept. 21,2020-- HarbourBioMed (HBM),a global,clinical-stage,innovative biopharmaceu...

Sanofi partners with Health2Sync to deliver an innovative digital solution to patients and healthcare providers, paving the way for digital therapeutics in diabetes
Health/ 2023-07-22
Sanofi partners with Health2Sync to deli...

Starting in Taiwan,this partnership aims to on-board clinics and hospitals nationwide over the next 3 years

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release